• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Ocular Therapeutix, Inc. - Common Stock (NQ:OCUL)

    11.50 +0.25 (+2.22%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,457,827
    Open 11.41
    Bid (Size) 11.27 (100)
    Ask (Size) 11.75 (300)
    Prev. Close 11.25
    Today's Range 11.20 - 11.65
    52wk Range 5.785 - 16.44
    Shares Outstanding 157,749,490
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    3 Stocks Under $50 with Questionable Fundamentals
    Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and... 
    Via StockStory
    News headline image
    3 of Wall Street’s Favorite Stocks Walking a Fine Line
    Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
    Via StockStory
    Topics Economy Supply Chain

    Performance

    YTD
    -2.7%
    -2.7%
    1 Month
    -28.6%
    -28.6%
    3 Month
    -0.2%
    -0.2%
    6 Month
    +15.9%
    +15.9%
    1 Year
    +29.5%
    +29.5%

    More News

    Read More
    News headline image
    Ocular Therapeutix (NASDAQ:OCUL) Surprises With Q3 CY2025 Sales
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 5, 2025 ↗
    Via Benzinga
    News headline image
    What's Next: Ocular Therapeutix's Earnings Preview ↗
    Via Benzinga
    News headline image
    Demystifying Ocular Therapeutix: Insights From 7 Analyst Reviews ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For May 5, 2025 ↗
    Via Benzinga
    News headline image
    Ocular Therapeutix Stock Skyrockets On Faster FDA Path For Vision Drug ↗
    Via Benzinga
    News headline image
    OCULAR THERAPEUTIX INC (NASDAQ:OCUL) Reports Mixed Q3 2025 Results with Narrower-Than-Expected Loss ↗
    Via Chartmill
    News headline image
    Eli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
    Via Benzinga
    News headline image
    Expert Outlook: Ocular Therapeutix Through The Eyes Of 4 Analysts ↗
    Via Benzinga
    News headline image
    This Broadcom Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
    Via Benzinga
    News headline image
    OCUL Sales Drop 18% ↗
    Via The Motley Fool
    News headline image
    OCULAR THERAPEUTIX INC (NASDAQ:OCUL) Reports Mixed Q2 2025 Earnings Amid Clinical Progress ↗
    Via Chartmill
    News headline image
    Carnival Posts Better-Than-Expected Earnings, Joins Liminatus Pharma, Coinbase Global, Uber And Other Big Stocks Moving Higher On Tuesday ↗
    Via Benzinga
    News headline image
    10 Health Care Stocks With Whale Alerts In Today's Session ↗
    Via Benzinga
    News headline image
    Analyst Expectations For Ocular Therapeutix's Future ↗
    Via Benzinga
    News headline image
    Ocular Therapeutix (OCUL) Stock Drops 13% After Q1 Earnings ↗
    Via Benzinga
    News headline image
    Expert Outlook: Ocular Therapeutix Through The Eyes Of 5 Analysts ↗
    Via Benzinga
    News headline image
    This Weyerhaeuser Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
    Via Benzinga
    News headline image
    What 4 Analyst Ratings Have To Say About Ocular Therapeutix ↗
    Via Benzinga
    News headline image
    Why Ocular Therapeutix Was Bumping Higher This Week ↗
    Via The Motley Fool
    News headline image
    Ocular Therapeutix Axpaxli Advances In Phase 3 For Wet AMD, Analyst Forecasts Huge Upside ↗
    Via Benzinga
    News headline image
    This Primoris Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
    Via Benzinga

    Frequently Asked Questions

    Is Ocular Therapeutix, Inc. - Common Stock publicly traded?
    Yes, Ocular Therapeutix, Inc. - Common Stock is publicly traded.
    What exchange does Ocular Therapeutix, Inc. - Common Stock trade on?
    Ocular Therapeutix, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Ocular Therapeutix, Inc. - Common Stock?
    The ticker symbol for Ocular Therapeutix, Inc. - Common Stock is OCUL on the Nasdaq Stock Market
    What is the current price of Ocular Therapeutix, Inc. - Common Stock?
    The current price of Ocular Therapeutix, Inc. - Common Stock is 11.50
    When was Ocular Therapeutix, Inc. - Common Stock last traded?
    The last trade of Ocular Therapeutix, Inc. - Common Stock was at 01/07/26 04:00 PM ET
    What is the market capitalization of Ocular Therapeutix, Inc. - Common Stock?
    The market capitalization of Ocular Therapeutix, Inc. - Common Stock is 1.81B
    How many shares of Ocular Therapeutix, Inc. - Common Stock are outstanding?
    Ocular Therapeutix, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.